Cargando…

ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial

BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilchrist, Gail, Potts, Laura, Radcliffe, Polly, Halliwell, Gemma, Dheensa, Sandi, Henderson, Juliet, Johnson, Amy, Love, Beverly, Gilchrist, Elizabeth, Feder, Gene, Parrott, Steve, Li, Jinshuo, McMurran, Mary, Kirkpatrick, Sara, Stephens-Lewis, Danielle, Easton, Caroline, Berbary, Cassandra, Landau, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147906/
https://www.ncbi.nlm.nih.gov/pubmed/34034690
http://dx.doi.org/10.1186/s12889-021-11012-3
_version_ 1783697731883106304
author Gilchrist, Gail
Potts, Laura
Radcliffe, Polly
Halliwell, Gemma
Dheensa, Sandi
Henderson, Juliet
Johnson, Amy
Love, Beverly
Gilchrist, Elizabeth
Feder, Gene
Parrott, Steve
Li, Jinshuo
McMurran, Mary
Kirkpatrick, Sara
Stephens-Lewis, Danielle
Easton, Caroline
Berbary, Cassandra
Landau, Sabine
author_facet Gilchrist, Gail
Potts, Laura
Radcliffe, Polly
Halliwell, Gemma
Dheensa, Sandi
Henderson, Juliet
Johnson, Amy
Love, Beverly
Gilchrist, Elizabeth
Feder, Gene
Parrott, Steve
Li, Jinshuo
McMurran, Mary
Kirkpatrick, Sara
Stephens-Lewis, Danielle
Easton, Caroline
Berbary, Cassandra
Landau, Sabine
author_sort Gilchrist, Gail
collection PubMed
description BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention to reduce IPA by men in substance use treatment was explored. A multicentre, parallel group individually randomised controlled feasibility trial and formative evaluation was conducted. Over three temporal cycles, 104 men who had perpetrated IPA towards a female (ex) partner in the past year were randomly allocated to receive the ADVANCE intervention + substance use treatment as usual (TAU) (n = 54) or TAU only (n = 50) and assessed 16-weeks post-randomisation. Participants’ (ex) partners were offered support and 27 provided outcome data. Thirty-one staff and 12 men who attended the intervention participated in focus groups or interviews that were analysed using the framework approach. Pre-specified criteria assessed the feasibility of progression to a definitive trial: 1) ≥ 60% of eligible male participants recruited; 2) intervention acceptable to staff and male participants; 3) ≥ 70% of participants followed-up and 4) levels of substance use and 5) IPA perpetrated by men in the intervention arm did not increase from average baseline level at 16-weeks post-randomisation. RESULTS: 70.7% (104/147) of eligible men were recruited. The formative evaluation confirmed the intervention’s acceptability. Therapeutic alliance and session satisfaction were rated highly. The overall median rate of intervention session attendance (of 14 compulsory sessions) was 28.6% (range 14.3–64.3% by the third cycle). 49.0% (51/104) of men and 63.0% (17/27) of their (ex) partners were followed-up 16-weeks post-randomisation. This increased to 100% of men and women by cycle three. At follow-up, neither substance use nor IPA perpetration had worsened for men in the intervention arm. CONCLUSIONS: It was feasible to deliver the ADVANCE intervention in substance use treatment services, although it proved difficult to collect data from female (ex)partners. While some progression criteria were met, others were not, although improvements were demonstrated by the third cycle. Lessons learned will be implemented into the study design for a definitive trial of the ADVANCE intervention. TRIAL REGISTRATION: ISRCTN79435190 prospectively registered 22nd May 2018. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11012-3.
format Online
Article
Text
id pubmed-8147906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81479062021-05-26 ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial Gilchrist, Gail Potts, Laura Radcliffe, Polly Halliwell, Gemma Dheensa, Sandi Henderson, Juliet Johnson, Amy Love, Beverly Gilchrist, Elizabeth Feder, Gene Parrott, Steve Li, Jinshuo McMurran, Mary Kirkpatrick, Sara Stephens-Lewis, Danielle Easton, Caroline Berbary, Cassandra Landau, Sabine BMC Public Health Research BACKGROUND: Substance use is a risk factor for intimate partner abuse (IPA) perpetration. Delivering perpetrator interventions concurrently with substance use treatment shows promise. METHODS: The feasibility of conducting an efficacy and cost-effectiveness trial of the ADVANCE 16-week intervention to reduce IPA by men in substance use treatment was explored. A multicentre, parallel group individually randomised controlled feasibility trial and formative evaluation was conducted. Over three temporal cycles, 104 men who had perpetrated IPA towards a female (ex) partner in the past year were randomly allocated to receive the ADVANCE intervention + substance use treatment as usual (TAU) (n = 54) or TAU only (n = 50) and assessed 16-weeks post-randomisation. Participants’ (ex) partners were offered support and 27 provided outcome data. Thirty-one staff and 12 men who attended the intervention participated in focus groups or interviews that were analysed using the framework approach. Pre-specified criteria assessed the feasibility of progression to a definitive trial: 1) ≥ 60% of eligible male participants recruited; 2) intervention acceptable to staff and male participants; 3) ≥ 70% of participants followed-up and 4) levels of substance use and 5) IPA perpetrated by men in the intervention arm did not increase from average baseline level at 16-weeks post-randomisation. RESULTS: 70.7% (104/147) of eligible men were recruited. The formative evaluation confirmed the intervention’s acceptability. Therapeutic alliance and session satisfaction were rated highly. The overall median rate of intervention session attendance (of 14 compulsory sessions) was 28.6% (range 14.3–64.3% by the third cycle). 49.0% (51/104) of men and 63.0% (17/27) of their (ex) partners were followed-up 16-weeks post-randomisation. This increased to 100% of men and women by cycle three. At follow-up, neither substance use nor IPA perpetration had worsened for men in the intervention arm. CONCLUSIONS: It was feasible to deliver the ADVANCE intervention in substance use treatment services, although it proved difficult to collect data from female (ex)partners. While some progression criteria were met, others were not, although improvements were demonstrated by the third cycle. Lessons learned will be implemented into the study design for a definitive trial of the ADVANCE intervention. TRIAL REGISTRATION: ISRCTN79435190 prospectively registered 22nd May 2018. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-11012-3. BioMed Central 2021-05-25 /pmc/articles/PMC8147906/ /pubmed/34034690 http://dx.doi.org/10.1186/s12889-021-11012-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gilchrist, Gail
Potts, Laura
Radcliffe, Polly
Halliwell, Gemma
Dheensa, Sandi
Henderson, Juliet
Johnson, Amy
Love, Beverly
Gilchrist, Elizabeth
Feder, Gene
Parrott, Steve
Li, Jinshuo
McMurran, Mary
Kirkpatrick, Sara
Stephens-Lewis, Danielle
Easton, Caroline
Berbary, Cassandra
Landau, Sabine
ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title_full ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title_fullStr ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title_full_unstemmed ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title_short ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
title_sort advance integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147906/
https://www.ncbi.nlm.nih.gov/pubmed/34034690
http://dx.doi.org/10.1186/s12889-021-11012-3
work_keys_str_mv AT gilchristgail advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT pottslaura advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT radcliffepolly advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT halliwellgemma advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT dheensasandi advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT hendersonjuliet advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT johnsonamy advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT lovebeverly advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT gilchristelizabeth advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT federgene advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT parrottsteve advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT lijinshuo advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT mcmurranmary advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT kirkpatricksara advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT stephenslewisdanielle advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT eastoncaroline advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT berbarycassandra advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial
AT landausabine advanceintegratedgroupinterventiontoaddressbothsubstanceuseandintimatepartnerabuseperpetrationbymeninsubstanceusetreatmentafeasibilityrandomisedcontrolledtrial